The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Open accessAbstract
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime example of the paradigms of a translocation-positive sarcoma: a genetically rather simple disease with a specific and neomorphic-potential therapeutic target, whose oncogenic role was irrefutably defined decades ago. This is a disease that by definition has micrometastatic disease at diagnosis and a dismal prognosis for patients with macrometastatic or recurrent disease. International collaborations have defined the current standard of care in prospective studies, delivering multiple cycles of systemic therapy combined with local treatment; both are associated with significant morbidity that may result in strong psychological and physical burden for survivors. Nevertheless, the combination of non-directed chemotherapeutics and ever-evolving local modalities nowadays achieve a realistic chance of cure for the majority of patients with Ewing sarcoma. In this review, we focus on the current standard of diagnosis and treatment while attempting to answer some of the most pressing questions in clinical practice. In addition, this review provides scientific answers to clinical phenomena and occasionally defines the resulting translational studies needed to overcome the hurdle of treatment-associated morbidities and, most importantly, non-survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–294 of 294
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors
Kushner, B. H., Kramer, K., Meyers, P. A., Wollner, N., & Cheung, N. V. (2000) · Medical and Pediatric Oncology · Cited by 68
Response to high‐dose ifosfamide in patients with advanced/recurrent Ewing sarcoma
Ferrari, S., del Prever, A. B., Palmerini, E., Staals, E. L., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., & Vanel, D. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21917 · Cited by 67
Bennani-Baı̈ti, I. M., Cooper, A. R., Lawlor, E. R., Kauer, M. O., Ban, J., Aryee, D. N. T., & Kovar, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0558 · Cited by 67
Self-citationFractures in Pediatric Ewing Sarcoma
Wagner, L. M., Neel, M. D., Pappo, A. S., Merchant, T. E., Poquette, C. A., Rao, B. N., & Galindo, C. R. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200112000-00003 · Cited by 66
Machado, I., Yoshida, A., Nieto, G., Abrahão‐Machado, L. F., Navarro, S., Cruz, J., Lavernia, J., Parafioriti, A., Picci, P., & Llombart‐Bosch, A. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.11.011 · Cited by 66
Andreou, D., Ranft, A., Gosheger, G., Timmermann, B., Ladenstein, R. L., Hartmann, W., Bauer, S., Baumhoer, D., van den Berg, H., Dijkstra, P. D. S., et al. (2019) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000000962 · Cited by 66
Self-citationYAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
Bierbaumer, L., Katschnig, A. M., Radic-Sarikas, B., Kauer, M. O., Petro, J. A., Högler, S., Gurnhofer, E., Pedot, G., Schäfer, B. W., Schwentner, R., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00294-8 · Cited by 66
Self-citationEphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
García-Monclús, S., López‐Alemany, R., Almacellas‐Rabaiget, O., Herrero‐Martín, D., Huertas-Martínez, J., Lagares‐Tena, L., Alba‐Pavón, P., Hontecillas‐Prieto, L., Mora, J., de Álava, E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31405 · Cited by 65
Gomez‐Brouchet, A., Mascard, É., Siegfried, A., Pinieux, G. D. B. D., Gaspar, N., Bouvier, C., Aubert, S., Marec‐Bérard, P., Piperno-Neumann, S., Marie, B., et al. (2019) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2018.12.015 · Cited by 65
Identification of Discrete Prognostic Groups in Ewing Sarcoma
Karski, E. E., McIlvaine, E. J., Segal, M. R., Krailo, M., Grier, H. E., Granowetter, L., Womer, R. B., Meyers, P. A., Felgenhauer, J. L., Marina, N. M., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25709 · Cited by 63
Self-citationBrunetto, A. L., Castillo, L. A., Petrilli, A. S., Macedo, C. D., Boldrini, É., da Costa, C. M. L., de Almeida, M. T. A., Kirst, D., Galindo, C. R., Pereira, W. V., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25562 · Cited by 62
de Álava, E., Lozano, M. D., Patiño‐García, A., Sierrasesúmaga, L., & Pardo-Mindán, F. J. (1998) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199806000-00005 · Cited by 62
Indelicato, D. J., Keole, S. R., Shahlaee, A. H., Shi, W., Morris, C. G., & Marcus, R. B. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.023 · Cited by 62
Hip transposition as a universal surgical procedure for periacetabular tumors of the pelvis
Gebert, C., Gosheger, G., & Winkelmann, W. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21212 · Cited by 62
Expression and clinical relevance of MET and ALK in Ewing sarcomas
Fleuren, E. D. G., Roeffen, M. H. S., Leenders, W. P. J., Flucke, U. E., Vlenterie, M., Schreuder, H. W. B., Boerman, O. C., van der Graaf, W. T. A., & Versleijen‐Jonkers, Y. M. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28047 · Cited by 61
The value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma
Rasper, M., Jabar, S., Ranft, A., Jürgens, H., Amler, S., & Dirksen, U. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25042 · Cited by 61
Self-citationAttia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D. A., Loggers, E. T., Livingston, M. B., Wright, J. A., Chawla, S. P., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5044 · Cited by 60
Local Control in Ewing Sarcoma of the Chest Wall: Results of the EURO-EWING 99 Trial
Bedetti, B., Wiebe, K., Ranft, A., Aebert, H., Schmidt, J., Jürgens, H., & Dirksen, U. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4630-0 · Cited by 59
Self-citationCharan, M., Dravid, P., Cam, M., Audino, A., Gross, A. C., Arnold, M. A., Roberts, R. D., Cripe, T. P., Pertsemlidis, A., Houghton, P. J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32743 · Cited by 59
Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma
Krook, M. A., Nicholls, L. A., Scannell, C. A., Chugh, R. K., Thomas, D. G., & Lawlor, E. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0668 · Cited by 58
Friedrich, P. M., Ortiz, R., Fuentes, S. L., Gamboa, Y., Chu‐Sanchez, M. S. A., Arambú, I. C., Montero, M., Báez, F., Galindo, C. R., & Antillón‐Klussmann, F. (2013) · Cancer · doi:10.1002/cncr.28339 · Cited by 57
3D tissue-engineered model of Ewing's sarcoma
Lamhamedi-Cherradi, S.-E., Santoro, M., Ramamoorthy, V., Menegaz, B. A., Bartholomeusz, G. A., Iles, L. R., Amin, H. M., Livingston, J. A., Mikos, A. G., & Ludwig, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.012 · Cited by 57
van der Ent, W., Jochemsen, A. G., Teunisse, A. F. A. S., Krens, G., Szuhai, K., Spaink, H. P., Hogendoorn, P. C. W., & Snaar-Jagalska, E. B. (2014) · The Journal of Pathology · doi:10.1002/path.4378 · Cited by 57
Chao, J., Budd, G. T., Chu, P. G., Frankel, P. H., Garcia, D., Junqueira, M., Loera, S., Somlo, G., Sato, J. K., & Chow, W. A. (2010) · PubMed · Cited by 57
Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize
Sáinz‐Jaspeado, M., Lagares‐Tena, L., Lasheras, J., Navid, F., Galindo, C. R., Mateo‐Lozano, S., Notario, V., Sanjuán, X., del Muro, X. G., Fabra, À., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0060 · Cited by 55
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
Harlow, M. L., Chassé, M. H., Boguslawski, E. A., Sorensen, K. M., Gedminas, J. M., Kitchen-Goosen, S. M., Rothbart, S. B., Taslim, C., Lessnick, S. L., Peck, A. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3511 · Cited by 55
Late Events in Pediatric Patients With Ewing Sarcoma/Primitive Neuroectodermal Tumor of Bone
McLean, T. W., Hertel, C. E., Young, M. L., Marcus, K. C., Schizer, M. A., Gebhardt, M. C., Weinstein, H. J., Pérez‐Atayde, A. R., & Grier, H. E. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00008 · Cited by 53
Shukla, N. N., Patel, J. A., Magnan, H., Zehir, A., You, D., Tang, J., Meng, F., Samoila, A., Slotkin, E. K., Ambati, S. R., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00028 · Cited by 52
Wang, S., Hwang, E. E., Guha, R., O'Neill, A. F., Melong, N., Veinotte, C. J., Saur, A. C., Wuerthele, K., Shen, M., McKnight, C. G., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0375 · Cited by 50
Wnt/β-catenin–activated Ewing sarcoma cells promote the angiogenic switch
Hawkins, A. G., Pedersen, E. A., Treichel, S., Temprine, K., Sperring, C. P., Read, J. A., Magnuson, B., Chugh, R. K., & Lawlor, E. R. (2020) · JCI Insight · doi:10.1172/jci.insight.135188 · Cited by 49
Yu, M., Wan, Y., & Zou, Q. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.06.007 · Cited by 48
Thomson, B. G., Hawkins, D. S., Felgenhauer, J. L., & Radich, J. P. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701939 · Cited by 47
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing’s sarcoma cells
Yang, L., Hu, H., Zielinska‐Kwiatkowska, A., & Chansky, H. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.129 · Cited by 47
The tactics and technique of musculoskeletal biopsy
Exner, G. U., Kurrer, M. O., Mamisch-Saupe, N., & Cannon, S. R. (2017) · EFORT Open Reviews · doi:10.1302/2058-5241.2.160065 · Cited by 47
Lissat, A., Joerschke, M., Shinde, D. A., Braunschweig, T. A., Meier, A., Makowska, A. M., Bortnick, R., Henneke, P., Herget, G. W., Gorr, T. A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1564-7 · Cited by 46
Shukla, N. N., Schiffman, J. D., Reed, D. R., Davis, I. J., Womer, R. B., Lessnick, S. L., & Lawlor, E. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00141 · Cited by 46
McCabe, M. G., Kirton, L., Khan, M., Fenwick, N., Dirksen, U., Gaspar, N., Kanerva, J. A., Kuehne, T., Longhi, A., Luksch, R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.11502 · Cited by 46
Self-citationRNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1
Erkizan, H. V., Schneider, J. A., Sajwan, K. P., Graham, G. T., Griffin, B. L., Chasovskikh, S., Youbi, S. E., Kallarakal, A. T., Chruszcz, M., Padmanabhan, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1328 · Cited by 45
Self-citationMRI Identification of the Osseous Extent of Pediatric Bone Sarcomas
Thompson, M. J., Shapton, J. C., Punt, S. E. W., Johnson, C. N., & Conrad, E. U. (2018) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999.0000000000000068 · Cited by 45
Neoplasm seeding in biopsy tract of the musculoskeletal system. A systematic review
Oliveira, M. P., Lima, P. M. D. A., da Silva, H. J., et al. (2014) · Acta Ortopédica Brasileira · doi:10.1590/1413-78522014220200422 · Cited by 44
Talleur, A. C., Navid, F., Spunt, S. L., McCarville, M. B., Wu, J. K., Mao, S., Davidoff, A. M., Neel, M. D., & Krasin, M. J. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.04.001 · Cited by 44
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Casey, D. L., Lin, T.-Y., & Cheung, N. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00537 · Cited by 44
McCabe, M. G., Moroz, V., Khan, M., Dirksen, U., Evans, A., Fenwick, N., Gaspar, N., Kanerva, J. A., Kühne, T., Longhi, A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.11007 · Cited by 43
Self-citationHawkins, D. S., Bradfield, S. M., Whitlock, J. A., Krailo, M., Franklin, J. R., Blaney, S. M., Adamson, P. C., & Reaman, G. H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20739 · Cited by 41
Samuel, G., Crow, J., Klein, J. B., Merchant, M. L., Nissen, E., Koestler, D. C., Laurence, K., Liang, X., Neville, K. A., Staggs, V. S., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27678 · Cited by 41
Feo, A. D., Sciandra, M., Ferracin, M., Felicetti, F., Astolfi, A., Pignochino, Y., Picci, P., Carè, A., & Scotlandi, K. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1675-1 · Cited by 40
Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma
Gerrand, C., Bate, J. M., Seddon, B. M., Dirksen, U., Randall, R. L., van de Sande, M. A. J., O’Donnell, P., Tuckett, J., Peake, D., Jeys, L. M., et al. (2020) · Clinical Sarcoma Research · doi:10.1186/s13569-020-00144-6 · Cited by 40
Self-citationBrodin, B. A., Wennerberg, K., Lidbrink, E. K., Brosjö, O., Potdar, S., Wilson, J. N., Ma, L., Moens, L., Hesla, A. C., Porovic, E., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0359-4 · Cited by 39
Mounessi, F., Lehrich, P., Haverkamp, U., Willich, N. A., Bölling, T., & Eich, H. T. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0304-z · Cited by 38
Rodríguez‐Núñez, P., Romero‐Pérez, L., Amaral, A. T., Puerto‐Camacho, P., Jordán, C., Marcilla, D., Grünewald, T. G. P., Alonso, J., de Álava, E., & Díaz‐Martín, J. (2019) · The Journal of Pathology · doi:10.1002/path.5379 · Cited by 38
Self-citationBurdach, S. E. G., Thiel, U., Schöniger, M., Haase, R., Wawer, A., Nathrath, M., Kabisch, H., Urban, C. E., Laws, H. ‐., Dirksen, U., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.184 · Cited by 36
Self-citationProcholecystokinin as Marker of Human Ewing Sarcomas
Reubi, J. C., Koefoed, P., Hansen, T. V. O., Stauffer, E., Rauch, D., Nielsen, F. C., & Rehfeld, J. F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1015-03 · Cited by 36
Precision diagnostics of Ewing’s sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts
Allegretti, M., Casini, B., Mandoj, C., Benini, S., Alberti, L., Novello, M., Melucci, E., Conti, L., Covello, R., Pescarmona, E. O., et al. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918774337 · Cited by 36
Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D. A., Loggers, E. T., Livingston, M. B., Wright, J. A., Chawla, S. P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.11005 · Cited by 36
Odri, G. A., Kim, P.-P., Lamoureux, F., Charrier, C., Battaglia, S., Amiaud, J., Heymann, D., Gouin, F., & Rédiní, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-169 · Cited by 34
Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma
Zoubek, A., Kovar, H., Kronberger, M., Amann, G., Windhager, R. H., Gruber, B., & Gadner, H. (1996) · European Journal of Pediatrics · doi:10.1007/bf01955264 · Cited by 34
Self-citationDiagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis
Kasalak, Ö., Overbosch, J., Adams, H. J. A., Dammann, A., Dierckx, R., Jutte, P. C., & Kwee, T. C. (2018) · Acta Radiologica · doi:10.1177/0284185118774953 · Cited by 34
Patient-derived xenograft models in musculoskeletal malignancies
Wan, L., Chao, T., Chen, R., Su, J., & Li, Z. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1487-6 · Cited by 34
Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall
Shamberger, R. C., & Grier, H. E. (2001) · Seminars in Pediatric Surgery · doi:10.1053/spsu.2001.24699 · Cited by 32
von Heyking, K., Calzada‐Wack, J., Göllner, S., Neff, F., Schmidt, O., Hensel, T., Schirmer, D., Fasan, A., Esposito, I., Müller‐Tidow, C., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12057 · Cited by 32
How PET/MR Can Add Value for Children with Cancer
Daldrup-Link, H. E. (2017) · Current Radiology Reports · doi:10.1007/s40134-017-0207-y · Cited by 31
Heinemann, M., Ranft, A., ten Langer, T. S., Jürgens, H., Kreyer, J., Vieth, V., Schäfers, M. A., Weckesser, M., Simon, T., Hassenpflug, W. A., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27011 · Cited by 31
Self-citationSchmidkonz, C., Krumbholz, M., Atzinger, A., Cordes, M., Goetz, T. I., Prante, O., Ritt, P., Schaefer, C., Agaimy, A., Hartmann, W., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04649-1 · Cited by 29
Self-citationAn immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning
Ren, E., Deng, Y.-J., Yuan, W., Wu, Z., Zhang, G., & Xie, Q. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03396-3 · Cited by 29
Yaniv, I., Cohen, I. J., Stein, J., Zilberstein, J., Liberzon, E., Atlas, O., Grunspan, A., Sverdlov, Y., Ash, S., Zaizov, R., et al. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20022 · Cited by 28
Circulating miR-125b as a biomarker of Ewing's sarcoma in Chinese children
Nie, C. L., Ren, W. H., Ma, Y.-T., Xi, J. S., & Han, B. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.29.12 · Cited by 28
Long‐term survival in patients with Ewing's sarcoma relapsing after completing therapy
Hayes, F. A., Thompson, E. I., Kumar, M., & Hustu, H. O. (1987) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950150506 · Cited by 27
Vo, K. T., Edwards, J. V., Epling, C. L., Sinclair, E., Hawkins, D. S., Grier, H. E., Janeway, K. A., Barnette, P., McIlvaine, E. J., Krailo, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2516 · Cited by 27
Self-citationKeole, S. R., Ashman, J. B., & Daniels, T. B. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000084 · Cited by 26
Guder, W. K., Hardes, J., Nottrott, M., Steffen, A. J., Dirksen, U., & Streitbürger, A. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-02028-3 · Cited by 26
Self-citationUnraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
de Groot, S., Röttgering, B., Gelderblom, H. A. J., Pijl, H., Szuhai, K., & Kroep, J. R. (2020) · Cancers · doi:10.3390/cancers12123568 · Cited by 25
O’Neill, A., Shah, N., Zitomersky, N. L., Ladanyi, M., Shukla, N. N., Üren, A., Loeb, D. M., & Toretsky, J. A. (2013) · Sarcoma · doi:10.1155/2013/450478 · Cited by 24
Self-citationBosma, S. E., Rueten‐Budde, A. J., Lancia, C., Ranft, A., Dirksen, U., Krol, A. D. G., Gelderblom, H. A. J., van de Sande, M. A. J., Dijkstra, P. D. S., & Fiocco, M. F. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27943 · Cited by 24
Self-citationSteinestel, K., Trautmann, M., Jansen, E.-P., Dirksen, U., Rehkämper, J., Mikesch, J., Gerke, J. S., Orth, M. F., Sannino, G., Arteaga, M. F., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12610 · Cited by 24
Self-citationPrzybył, J., Kozak, K., Koseła-Paterczyk, H., Falkowski, S., Świtaj, T., Ługowska, I., Szumera‐Ciećkiewicz, A., Ptaszyński, K., Grygalewicz, B., Chechlińska, M., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0109-2 · Cited by 23
Su, Z., Indelicato, D. J., Vega, R. B. M., & Bradley, J. A. (2020) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12870 · Cited by 23
Schlegel, M., Zeumer, M., Prodinger, P. M., Woertler, K., Steinborn, M., von Eisenhart‐Rothe, R., Burdach, S. E. G., Rechl, H., & von Luettichau, I. (2018) · Oncology · doi:10.1159/000487142 · Cited by 22
Connell, L. M., Gazdová, J., Beck, K., Srivastava, S., Harewood, L., Stewart, P., Hübschmann, D., Stenzinger, A., Glimm, H., Heilig, C. E., et al. (2020) · Cancers · doi:10.3390/cancers12123627 · Cited by 22
Hesketh, A. J., Maloney, C. W., Behr, C. A., Edelman, M. C., Glick, R. D., Al‐Abed, Y., Symons, M. H., Soffer, S. Z., & Steinberg, B. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145197 · Cited by 21
Miyake, K., Kiyuna, T., Kawaguchi, K., Higuchi, T., Oshiro, H., Zhang, Z., Wangsiricharoen, S., Razmjooei, S., Li, Y., Nelson, S. D., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03782-w · Cited by 20
Doyle, L. A., Wong, K., Bueno, R., et al. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.08.004 · Cited by 18
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
Sciandra, M., Feo, A. D., Parra, A., Landuzzi, L., Lollini, P., Manara, M. C., Mattia, G., Pontecorvi, G., Baricordi, C., Guerzoni, C., et al. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00567-2 · Cited by 18
de Groot, S., Gelderblom, H. A. J., Fiocco, M. F., Bovée, J. V. M. G., van der Hoeven, J. J. M., Pijl, H., & Kroep, J. R. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s123726 · Cited by 15
Lee, S., Lim, S., & Cho, D. H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6323 · Cited by 15
(Immuno)histological Analysis of Ewing Sarcoma
Marcilla, D., Machado, I., Grünewald, T. G. P., Civantos, G., Llombart-Bosch, A., & de Álava, E. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_5 · Cited by 15
Self-citationInitial diagnostic management of pediatric bone tumors
Interiano, R. B., Malkan, A. D., Loh, A. H. P., Hinkle, N. M., Wahid, F. N., Bahrami, A., Mao, S., Wu, J., Bishop, M. W., Neel, M. D., et al. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.02.068 · Cited by 13
Ulaner, G. A., Hwang, S., Landa, J., Lefkowitz, R. A., & Panicek, D. M. (2013) · International Orthopaedics · doi:10.1007/s00264-013-1824-6 · Cited by 13
Bailey, K. M., Julian, C. M., Klinghoffer, A. N., Bernard, H., Lucas, P. C., & McAllister‐Lucas, L. M. (2019) · Oncotarget · doi:10.18632/oncotarget.26939 · Cited by 13
Dirksen, U., Koch, R., Bhadri, V. A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.11523 · Cited by 12
Self-citationInactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma
Pan, B., Bu, X., Cao, M., Zhang, X., Huo, T., Li, Z., Gao, X., Jing, L., Luo, X., Hu, F., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03431-3 · Cited by 10
Dirksen, U., Bhadri, V. A., Brichard, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.11501 · Cited by 8
Self-citationImage-guided core needle biopsy for Ewing sarcoma of bone: a 10-year single-institution review
Kalus, S., Vidoni, A., Oliveira, I., & Saifuddin, A. (2020) · European Radiology · doi:10.1007/s00330-020-06926-2 · Cited by 7
The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
Berning, P., Hennemann, C., Tulotta, C., Schaefer, C., Lechtape, B., Hotfilder, M., Gourari, Y. E., Jürgens, H., Snaar-Jagalska, E. B., Hempel, G., et al. (2020) · Cancers · doi:10.3390/cancers12040904 · Cited by 4
Self-citationPathologische Frakturen bei malignen Knochentumoren
Schultheiß, M., Traub, S. E., & von Baer, A. (2014) · Der Unfallchirurg · doi:10.1007/s00113-013-2474-2 · Cited by 2
Cited by
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04160-1 · Cited by 54
Metadata
- Authors
- Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., Shulman, D. S., Streitbürger, A., Timmermann, B., Toretsky, J. A., Uhlenbruch, Y., Vieth, V., Grünewald, T. G. P., & Dirksen, U.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-04-14
- Volume
- 10
- Issue
- 8
- Pages
- 1685
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3152750978
- Cited by
- 271
- References
- 294
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.